Viking Therapeutics, Inc. (VKTX) Dividend History
Income profile from 2012 to 2025 with payout safety and yield-on-cost trend
VKTX Dividend Income Check
Safety
Payout ratio data not available yet.
Consistency
0 straight years of dividend increases.
Income Trend
Yield on cost trend needs more history.
VKTX Dividend Scorecard
Yield & Income
Payout Safety
Growth
Total Returns
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.
VKTX Dividend History
No dividend payment history available
Dividend Analysis
Payout Safety
Viking Therapeutics, Inc. has limited earnings payout data (Unknown).
Piotroski F-Score: 2/9 — weak financial health.
Growth Track Record
VKTX does not have a current streak of consecutive dividend increases.
Total Shareholder Returns
Beyond cash dividends, VKTX returns capital through share repurchases. The combined picture: 0.0% total shareholder yield.
Income Trend & Total Return
The 5-year total return is 435.3%.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $267,626 today.
VKTX Dividend vs Peers
Comparable companies in the same industry
VKTX Annual Dividend History (2012–2025)
14 years of dividend data
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | — | 0 | $-3.19 | — | — | — |
| 2024 | $0.00 | — | 0 | $-1.01 | — | — | — |
| 2023 | $0.00 | — | 0 | $-0.91 | — | — | — |
| 2022 | $0.00 | — | 0 | $-0.88 | — | — | — |
| 2021 | $0.00 | — | 0 | $-0.70 | — | — | — |
| 2020 | $0.00 | — | 0 | $-0.50 | — | — | — |
| 2019 | $0.00 | — | 0 | $-0.36 | — | — | — |
| 2018 | $0.00 | — | 0 | $-0.38 | — | — | — |
| 2017 | $0.00 | — | 0 | $-0.79 | — | — | — |
| 2016 | $0.00 | — | 0 | $-0.90 | — | — | — |
See VKTX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VKTX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare VKTX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonVKTX — Frequently Asked Questions
Quick answers to the most common questions about buying VKTX stock.
How much dividend does VKTX pay per share?
Viking Therapeutics, Inc. (VKTX) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made quarterly.
When is VKTX's next ex-dividend date?
VKTX's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. VKTX typically pays dividends quarterly.
Is VKTX's dividend safe?
VKTX's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The dividend history does not yet show a prolonged growth streak.
How many years has VKTX increased its dividend?
VKTX has not maintained a consecutive growth streak recently. The 5-year dividend CAGR is N/A.
How often does VKTX pay dividends?
Viking Therapeutics, Inc. pays dividends quarterly. The trailing 12-month total is N/A per share. Dividend data on this page covers 13+ years from 2012 to 2025.
How much would $10,000 invested in VKTX grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in VKTX five years ago would be worth approximately $53,526 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is VKTX's yield on cost for long-term holders?
VKTX's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.